Belfast Telegraph

Tuesday 23 September 2014

Firm's osteoporosis R&D facility on way to Derry

A medical tests company is setting up a research and development centre in Londonderry where it will develop a test to identify osteoporosis risk.

Crescent Diagnostics is based at University College, Dublin but also has a lab at the Clinical Translation Research and Innovation Centre in Derry. The project has received £23,000 in assistance from Invest Northern Ireland and is likely to take six months to complete.

Invest NI chief executive Alastair Hamilton said the company aimed to create a breakthrough test identifying people at high risk of a hip fracture, "the most devastating consequence of osteoporosis".

"Osteoporosis has become a major public health issue and Crescent has identified a market need for an improved diagnostic tool.

"By carrying out the research and development project in Londonderry, Crescent is planning to tap into the research capability at Queen's University as well as the extensive facilities at C-TRIC.

Crescent chief executive Brendan Farrell said: "Our technology will help clinicians identify at-risk patients early, revolutionising the diagnosis of the disease."

COMMENT RULES: Comments that are judged to be defamatory, abusive or in bad taste are not acceptable and contributors who consistently fall below certain criteria will be permanently blacklisted. The moderator will not enter into debate with individual contributors and the moderator’s decision is final. It is Belfast Telegraph policy to close comments on court cases, tribunals and active legal investigations. We may also close comments on articles which are being targeted for abuse. Problems with commenting? customercare@belfasttelegraph.co.uk

Comment

More

Company Profiles

More

Help & Advice

More

People on the move

More